Case Reports of Patients having Intermediate Soft Tissue Tumors

중등도 악성화 경향을 보이는 연부 조직 종양 환자의 치험례

  • Kim, Kee Woong (Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University) ;
  • Kim, Jeong Tae (Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University) ;
  • Kim, Youn Hwan (Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University) ;
  • Baik, Seung Sam (Department of Pathology, College of Medicine, Hanyang University)
  • 김기웅 (한양대학교 의과대학 성형외과학 교실) ;
  • 김정태 (한양대학교 의과대학 성형외과학 교실) ;
  • 김연환 (한양대학교 의과대학 성형외과학 교실) ;
  • 백승삼 (한양대학교 의과대학 조직병리학 교실)
  • Published : 2009.05.15

Abstract

Purpose: Malignant soft tissue tumors, known as sarcomas, are well known to be locally aggressive, frequently metastatic, and highly recurrent. In other hands, intermediate soft tissue tumors often recur locally with adjacent tissue infiltration so the clinical management is difficult as sarcoma. In the present study, we evaluate the clinical course of the intermediate soft tissue tumors and consider the management plan for those. Methods: From March, 1998 to April 2008, total 3 patients of intermediate soft tissue tumors underwent operations. A patient with fibrohistiocytic neoplasm, a free flap reconstruction was performed, and he underwent several more operations because of recurrences. Other patients with desmoids - type fibromatosis showed local invasion and adhesion, and one of them underwent reoperation due to local recurrence. Results: 2 of 3 patients underwent recurrences of tumors and reoperations were performed. In another patient with no recurrence, follow-up period was just 5 months, so there may be recurrence of tumor in long term follow-up. Conclusion: The clinical course of intermediate soft tissue tumors shows high recurrence rate. So clinically, intermediate soft tissue tumors should be considered as sarcomas. The successful management requires wide resection, carefully planned reconstruction, and close follow up with radiologic evaluation.

Keywords

References

  1. Fletcher CD, Unni KK, Mertens F: Pathology and genetics of tumours of soft tissue and bone. 1st edition, Lyon, IARC Press, 2002, p 12
  2. Fletcher CD: The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48: 3, 2006 https://doi.org/10.1111/j.1365-2559.2005.02284.x
  3. Yu W, Tsoukas MM, Chapman SM, Rosen JM: Surgical treatment for dermatofibrosarcoma protuberans: the Dartmouth experience and literature review. Ann Plast Surg 60: 288, 2008 https://doi.org/10.1097/SAP.0b013e31805342eb
  4. Flugstad DL, Wilke CP, McNutt MA, Welk RA, Hart MJ, McQuinn WC: Importance of surgical resection in the successful management of soft tissue sarcoma. Arch Surg 134: 856, 1999 https://doi.org/10.1001/archsurg.134.8.856
  5. Hohenberger P, Wysocki WM: Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose? Oncologist 13: 175, 2008 https://doi.org/10.1634/theoncologist.2007-0165
  6. Koo JH, Kang KJ, Song KH, Park SD, Chung KY: Seven cases of desmoid tumor of trunk. J Korean Surg Soc 56: 143, 1999
  7. Kim HC, Suh BS, Lee DH, Ahn BY, Chung CS, Kang GH, Ha HK, Kim JC: A combined treatment of tamoxifen, goserelin, and sulindac in 2 cases of recurrent desmoid tumor in the abdomen. J Korean Soc Coloproctol 15: 339 1999
  8. Seo SW, Park SM: Diagnostic efficacy of PET in soft tissue tumors: comparative study with conventional methods. J Korean Bone Joint Tumor Soc 11: 32, 2005